Modeling of cardiac ischaemia and reperfusion injury: a human-based in vitro model using iPS-derived cardiomyocytes

被引：0
|
作者：
Pinho, J. [1 ]
Scrimgeour, N. R. [1 ]
Stolen, T. [1 ]
Solvang-Garten, K. [1 ]
Sharma, A. [2 ]
Fonseca, D. Miranda [2 ]
Smith, G. [3 ]
Hoydal, M. [1 ]
机构：
[1] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway
[2] Norwegian Univ Sci & Technol, Prote & Metabol Core Facil PROMEC, Trondheim, Norway
[3] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1095
引用
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [1] An application of human iPS-derived cardiomyocytes in cardiac safety screening assay
    Kurokawa, Junko
    Ashihara, Takashi
    Furukawa, Tetsushi
    Kanda, Yasunari
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S57 - S57
  • [2] An iPS-derived in vitro model of human atrial conduction
    Biendarra-Tiegs, Sherri M.
    Yechikov, Sergey
    Shergill, Bhupinder
    Brumback, Brittany
    Takahashi, Kentaro
    Shirure, Venktesh S.
    Gonzalez, Ruth Estelle
    Houshmand, Laura
    Zhong, Denise
    Weng, Kuo-Chan
    Silva, Jon
    Smith, Timothy W.
    Rentschler, Stacey L.
    George, Steven C.
    [J]. PHYSIOLOGICAL REPORTS, 2022, 10 (18):
  • [3] Modeling ischemic heart disease: only matured human iPS-derived cardiomyocytes are sensitive to ischemic injury
    Peters, M. C.
    Van Adrichem, I.
    Doevendans, P. A. M.
    Chamuleau, S. A. J.
    Neef, K.
    Sluijter, J. P. G.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 3251 - 3251
  • [4] A Human iPS-derived In Vitro Model of 3D Vascularized Cardiac Muscle
    Kurokawa, Y.
    Tran, D.
    Moya, M.
    Sobrino, A.
    Alonzo, L.
    Heylman, C.
    Tu, C.
    Lock, L.
    Conklin, B.
    Hughes, C.
    George, S.
    [J]. TISSUE ENGINEERING PART A, 2014, 20 : S31 - S31
  • [5] Evaluation of ionotropic and chronotropic compounds in vitro using human ips-derived cardiomyocytes and impedance-based contractility assay
    Zhang, Xiaoyu
    Xi, Biao
    Wang, Xiaobo
    Xu, Xiao
    Abassi, Yama A.
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2015, 76 : 96 - 96
  • [6] In vitro pharmacology and safety testing using human iPS-derived Cor.4U cardiomyocytes
    Kettenhofen, Ralf
    Tressat, Kristina
    Kolossov, Eugen
    Hebeisen, Simon
    Jaehne, Evelyn
    Ehlich, Andreas
    Schwengberg, Silke
    Bohlen, Heribert
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2013, 68 (01) : E7 - E7
  • [7] Identification of CV liabilities in the xCELLigence system using human iPS-derived cardiomyocytes
    Kazusa, Katsuyuki
    Watanabe, Yudai
    Nagata, Keisuke
    Sato, Yumiko
    Fujimori, Chikara
    Shirakawa, Takafumi
    Okada, Akinobu
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 344 - 344
  • [8] A novel in vitro model for evaluating drug-induced QT prolongation using genetically modified human iPS-derived cardiomyocytes
    Li, Min
    Kanda, Yasunari
    Ashihara, Takashi
    Sasano, Tetsuo
    Sekino, Yuko
    Furukawa, Tetsushi
    Kurokawa, Junko
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 86P - 86P
  • [9] Differentiation of iPS-derived cardiac mesoderm cells into cardiomyocytes using inducible shRNA technology
    Duran, A. Garcia
    Nazari-Shafti, T.
    Kurtz, A.
    Falk, V.
    Gossen, M.
    Stamm, C.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 1532 - 1532
  • [10] Assessment of TdP risk using human iPS-derived cardiomyocytes by JiCSA 60 compounds
    Yamazaki, Daiju
    Ando, Hiroyuki
    Yoshinaga, Takashi
    Yamamoto, Wataru
    Asakura, Keiichi
    Taniguchi, Tomohiko
    Uda, Muneaki
    Kanda, Yasunari
    Osada, Tomoharu
    Hayashi, Seiji
    Miyamoto, Norimasa
    Kasai, Chieko
    Tashibu, Hiroyuki
    Inutsuka, Takashi
    Sugiyama, Atsushi
    Sawada, Kohei
    Sekino, Yuko
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S223 - S223
12345